Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.89	1.39	2.55	2.02	2.28	2.49
Cash & Short-Term Investments	0.89	1.39	2.55	2.02	2.28	2.49
Cash Growth	-41.90%	-45.47%	26.03%	-11.32%	-8.36%	-91.63%
Receivables	2.07	2.62	5.52	0.38	1.04	0.2
Inventory	1.31	1.64	1.71	2.38	4.39	7.09
Prepaid Expenses	0.53	0.89	1.13	1.07	0.99	0.84
Other Current Assets	0.22	0.23	0.6	0.45	0.39	0.64
Total Current Assets	5.02	6.77	11.51	6.29	9.09	11.26
Property, Plant & Equipment	0.97	1.58	2.4	2.87	3.63	4.19
Long-Term Investments	17.19	15.04	20.98	38.8	43.72	43.79
Other Long-Term Assets	0.17	0.22	0.3	0.26	0.3	0.3
Total Assets	23.34	23.6	35.18	48.23	56.73	59.54
Accounts Payable	0.75	0.59	0.52	0.3	0.26	0.52
Accrued Expenses	21.62	21.32	18.59	14.45	8.93	6.94
Short-Term Debt	11.4	10.47	11.34	9.18	3.6	5.52
Current Portion of Long-Term Debt	16.8	17.01	16.38	14.66	10.16	5.48
Current Portion of Leases	0.35	2.42	1.64	0.7	0.74	1.14
Current Unearned Revenue	10	10	10	10	-	-
Other Current Liabilities	1.15	1.74	3.04	5.04	13.41	3.78
Total Current Liabilities	62.08	63.56	61.51	54.32	37.1	23.38
Long-Term Debt	2.26	2.25	2.23	3.73	4.65	3.37
Long-Term Leases	1.58	0.82	1.84	2.55	3.26	3.47
Long-Term Unearned Revenue	-	-	-	-	10	10
Other Long-Term Liabilities	13.13	13.47	17.36	21.71	23.17	24.47
Total Liabilities	79.05	80.08	82.94	82.32	78.18	64.69
Common Stock	0.06	0.06	0.06	0.05	0.05	0.05
Additional Paid-In Capital	225.91	225.9	225.33	220.82	220.02	218.73
Retained Earnings	-266.04	-262.58	-256.12	-252.34	-241.27	-225.08
Comprehensive Income & Other	-15.63	-19.86	-17.03	-2.62	-0.26	1.14
Shareholders' Equity	-55.7	-56.48	-47.76	-34.09	-21.45	-5.16
Total Liabilities & Equity	23.34	23.6	35.18	48.23	56.73	59.54
Total Debt	32.39	32.96	33.42	30.82	22.41	18.99
Net Cash (Debt)	-31.51	-31.57	-30.88	-28.8	-20.13	-16.5
Net Cash Per Share	-0.49	-0.50	-0.58	-0.58	-0.41	-0.34
Filing Date Shares Outstanding	63.87	63.87	61.85	50.93	49.31	49.31
Total Common Shares Outstanding	63.87	63.87	61.85	49.58	49.31	48.99
Working Capital	-57.06	-56.79	-50	-48.03	-28.01	-12.13
Book Value Per Share	-0.87	-0.88	-0.77	-0.69	-0.43	-0.11
Tangible Book Value	-55.7	-56.48	-47.76	-34.09	-21.45	-5.16
Tangible Book Value Per Share	-0.87	-0.88	-0.77	-0.69	-0.43	-0.11
Machinery	0.49	0.39	0.48	0.47	0.45	0.45
Construction In Progress	-	-	-	-	0.06	-
Leasehold Improvements	0.02	0.02	0.04	0.04	0.04	0.04

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.